Highly Active Anti-retroviral Therapy Associated Hepatotoxicity: Case Report and Discussion
Sai Deepak Gali1, Deepishka Pemmasani1★, Durga Prasad Thammi Setty1★ Corresponding author
- 1Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy Practice, Jawaharlal Nehru Technological University, Anantapuramu, Andhra Pradesh, INDIA.
CORRESPONDENCE
Deepishka Pemmasani
Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy Practice, Jawaharlal Nehru Technological University, Anantapuramu, Andhra Pradesh, INDIA.
Volume 12, Issue 2 · pp. 126–128 · PUBLISHED · DOI: 10.5530/ijopp.12.2.26
ABSTRACT
Anti-retroviral Drugs (ARV) drugs are always given in combination of two or three drugs like Tenofovir, Lamivudine, Efavirenz and is often referred as HAART therapy. Though it has potential to reduce the disease progression, it is often associated with adverse drug reactions like hepatotoxicity which has been the concern till date. We present here a case of 42-year-old patient who developed hepatotoxicity induced by ARV drugs with apparent risk factors of female gender and higher CD4 count. This case stresses the need for careful evaluation, regular monitoring and prompt omission of drug on suspicion of hepatotoxicity in reducing the mortality and morbidity in HIV infected patients.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gali, S. D., Pemmasani, D., & Setty, D. P. T. (). Highly Active Anti-retroviral Therapy Associated Hepatotoxicity: Case Report and Discussion. Indian Journal of Pharmacy Practice, 12(2), 126–128. https://doi.org/10.5530/ijopp.12.2.26